Praxis Precision Medicines Inc. (PRAX) PT Raised to $75 at Jefferies, 'Catalyst-Rich 2024 Kicks Off'
Tweet Send to a Friend
Jefferies analyst Kambiz Yazdi raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $75.00 (from $60.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
